Portal Hypertension Clinical Trials in Hong Kong
2 recruitingHong Kong, Hong Kong
Showing 1–2 of 2 trials
Recruiting
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
CirrhosisPortal HypertensionVarices, Esophageal
Chinese University of Hong Kong375 enrolled8 locationsNCT06549673
Recruiting
Phase 4
Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease
Advanced Chronic Liver DiseasePortal HypertensionHepatic Decompensation
Chinese University of Hong Kong474 enrolled1 locationNCT06449339